The purpose of this study was to evaluate the relationship between the endolymphatic space image obtained using magnetic resonance imaging (MRI) and the results of electrocochleography. Electrocochleography recordings were obtained from 25 ears of 24 patients, who underwent MRI 1 day after the intratympanic injection of gadolinium diethylenetriamine pentaacetic acid bismethylamide. The average summating potential to action potential (SP/AP) ratio in patients with significant endolymphatic hydrops in the cochlea was 54 ± 17%. However, in some patients who had significant endolymphatic hydrops in the cochlea, the SP/AP ratio was not enlarged. This may imply that elevation of the SP/AP ratio is related to not only the degree of endolymphatic hydrops but also to the persistence of hydrops.

Keywords:
Cochlear hydrops, Electrocochleography, Intratympanic gadolinium administration, Ménière’s disease
1.
Chung WH, Cho DY, Choi JY, Hong SH: Clinical usefulness of extratympanic electrocochleography in the diagnosis of Ménière’s disease. Otol Neurotol 2004;25:144–149.
2.
Conlon BJ, Gibson WPR: Electrocochleography in the diagnosis of Ménière’s disease. Acta Otolaryngol 2000;120:480–483.
3.
Committee on Hearing and Equilibrium: Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Ménière’s disease. Otolaryngol Head Neck Surg 1995;113:181–185.
4.
Ferraro JA, Durrant JD: Electrocochleography in the evaluation of patients with Ménière’s disease/endolymphatic hydrops. J Am Acad Audiol 2006;17:45–68.
5.
Ge X, Shea JJ Jr: Transtympanic electrocochleography: a 10-year experience. Otol Neurotol 2002;23:799–805.
6.
Griswold MA, Jakob PM, Heidemann RM, Nittka M, Jellus V, Wang J, Kiefer B, Hasse A: Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002;47:1202–1210.
7.
Hwang JH, Ho HC, Hsu CJ, Yang WS, Liu TC: Diagnostic value of combining bilateral electrocochleography results for unilateral Ménière’s disease. Audiol Neurotol 2008;13:365–369.
8.
Kitahara M, Takeda T, Yazawa Y, Matsubara H: Electrocochleography in the diagnosis of Ménière’s disease; in Vosteen KH, Schuknecht H, Pfalz CR, et al (eds): Ménière’s Disease. Pathogenesis, Diagnosis and Treatment. Stuttgart, Thieme, 1981, pp 163–169.
9.
Klockhoff I, Lindblom U: Endolymphatic hydrops revealed by glycerol test. Preliminary report. Acta Otolaryngol 1966;61:459–462.
10.
Lin MY, Timmer FC, Oriel BS, Zhou G, Guinan JJ, Kujawa SG, Herrmann BS, Merchant SN, Rauch SD: Vestibular evoked myogenic potentials (VEMP) can detect asymptomatic sacclar hydrops. Laryngoscope 2006;116:987–992.
11.
Mori N, Asai H, Sakagami M: The role of summating potential in the diagnosis and management of Ménière’s disease. Acta Otolaryngol Suppl 1993;501:51–53.
12.
Naganawa S, Komada T, Fukatsu H, Ishigaki T, Takizawa O: Observation of contrast enhancement in the cochlear fluid space of healthy subjects using a 3D-FLAIR sequence at 3 Tesla. Eur Radiol 2006;16:733–737.
13.
Naganawa S, Satake H, Iwano S, Fukatsu H, Sone M, Nakashima T: Imaging endolymphatic hydrops at 3 Tesla using 3D-FLAIR with intratympanic Gd-DTPA administration. Magn Reson Med Sci 2008a;7:85–91.
14.
Naganawa S, Satake H, Kawamura M, Fukatsu H, Sone M, Nakashima T: Separate visualization of endolymphatic space, perilymphatic space and bone by a single pulse sequence: 3D-inversion recovery imaging utilizing real reconstruction after intratympanic Gd-DTPA administration at 3 Tesla. Eur Radiol 2008b;18:920–924.
15.
Nakashima T, Naganawa S, Pyykkö I, Gibson WPR, Sone M, Nakata S, Teranishi M: Grading of endolymphatic hydrops using magnetic resonance imaging. Acta Otolaryngol Suppl 2009;129:5–8.
16.
Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H, Nakata S, Katayama N, Ishida IM: Visualization of endolymphatic hydrops in patients with Ménière’s disease. Laryngoscope 2007;117:415–420.
17.
Ohashi T, Ochi K, Okada T, Takeyama I: Long-term follow-up of electrocochleogram in Ménière’s disease. ORL J Otorhinolaryngol Relat Spec 1991;53:131–136.
18.
Pappas DG Jr, Pappas DG Sr, Carmichael L, Hyatt DP, Toohey LM: Extratympanic electrocochleography: diagnostic and predictive value. Am J Otol 2000;21:81–87.
19.
Schuknecht HF: Delayed endolymphatic hydrops. Ann Otol Rhinol Laryngol 1978;87:743–748.
20.
Schuknecht HF, Suzuka Y, Zimmermann C: Delayed endolymphatic hydrops and its relationship to Ménière’s disease. Ann Otol Rhinol Laryngol 1990;99:843–853.
21.
Bonucci AS, Hyppolito MA: Comparison of the use of tympanic and extratympanic electrodes for electrocochleography. Laryngoscope 2009;119:563–566.
22.
Sugiura M, Naganawa S, Teranishi M, Nakashima T: Three-dimensional fluid-attenuated inversion recovery magnetic resonance imaging findings in patients with sudden sensorineural hearing loss. Laryngoscope 2006;116:1451–1454.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.